EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Autoimmune Encephalitis in Acute Care—Pathology, Diagnosis, and Management

Suneesh Thilak iD, David Okoh iD, William Scotton iD, Shanika Samarasekera iD, Vikram Patil, Suresh Renukappa iD, Andrew Macduff iD, Subashini Suresh iD, Rajeev Krishnadas iD, Tonny Veenith iD

Advanced Science · 2026-07 · 13 (37)

DOI: 10.1002/advs.202519049 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 29.03.2026. Verfasst von Suneesh Thilak und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesia, Critical Care and Acute Care, Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom. Hauptthemen laut MEDLINE: Encephalitis, Hashimoto Disease, Immunotherapy. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune encephalitis (AE) is characterized by immune‐mediated inflammation of the brain parenchyma, presenting with various neurological syndromes, including but not limited to seizures, altered consciousness, neuropsychiatric symptoms, and movement disorders. A significant proportion of patients with AE develop life‐threatening complications that require hospital and potentially ICU admission. These patients present unique diagnostic and therapeutic challenges, presenting with a range of neurological emergencies such as refractory status epilepticus, severe dysautonomia, coma, and respiratory failure. Diagnosis relies on a combination of clinical criteria, detection of autoantibodies in serum and cerebrospinal fluid, neuroimaging, and electroencephalography, though antibody‐negative AE poses considerable diagnostic difficulty. Management is centered on prompt initiation of first‐line immunotherapies (corticosteroids, plasma exchange, and intravenous immunoglobulin therapy) and escalation to second‐line or emerging targeted therapies (e.g., rituximab, cyclophosphamide, IL‐6 inhibitors, proteasome inhibitors) in refractory cases, alongside aggressive supportive care for neurological and systemic complications. The prognosis is variable and influenced by factors such as the specific autoantibody, the timeliness of treatment, and the severity of complications. Long‐term sequelae, including cognitive and psychiatric impairments, are common among survivors. This review provides a synthesis of current knowledge on AE in acute and intensive care. Given these diagnostic challenges and the potential for severe symptom presentation, the authors believe that this review is an essential addition to the discourse. This review covers pathophysiology, epidemiology, clinical manifestations, diagnostic approaches, immunotherapeutic strategies, management of critical complications, syndrome‐specific considerations, prognostication, intensive care unit‐related complications, and future research priorities to support optimal care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EncephalitisHashimoto DiseaseImmunotherapyHumansPrognosis

Stichwörter der Autor:innen

autoimmune encephalitiscritical careimmunotherapyneurocritical careneuroimmunologyneurological emergenciesprognosisstatus epilepticus

Autor:innen und Institutionen

  • Department of Anaesthesia, Critical Care and Acute Care, Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom.
  • Department of Neurology, Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom.
  • Department of Neurology University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Department of Radiology, JSS Medical College, JSS AHER, Mysuru, India.
  • JSS AHER - Wolverhampton Centre For Future Health and Policy Innovation, Mysuru, India.
  • Faculty of Science and Engineering, University of Wolverhampton, Wolverhampton, United Kingdom.

ORCID-Profile: Suneesh Thilak, David Okoh, William Scotton, Shanika Samarasekera, Suresh Renukappa, Andrew Macduff, Subashini Suresh, Rajeev Krishnadas, Tonny Veenith

Zitieren

APA

Thilak, S., Okoh, D., Scotton, W., Samarasekera, S., Patil, V., Renukappa, S., Macduff, A., Suresh, S., Krishnadas, R., & Veenith, T. (2026). Autoimmune Encephalitis in Acute Care—Pathology, Diagnosis, and Management. Advanced Science, 13(37). https://doi.org/10.1002/advs.202519049

Vancouver

Thilak S, Okoh D, Scotton W, Samarasekera S, Patil V, Renukappa S, et al. Autoimmune Encephalitis in Acute Care—Pathology, Diagnosis, and Management. Advanced Science. 2026;13(37). doi:10.1002/advs.202519049

BibTeX
@article{Thilak2026,
  author = {Thilak, Suneesh and Okoh, David and Scotton, William and Samarasekera, Shanika and Patil, Vikram and Renukappa, Suresh and Macduff, Andrew and Suresh, Subashini and Krishnadas, Rajeev and Veenith, Tonny},
  title = {Autoimmune Encephalitis in Acute Care—Pathology, Diagnosis, and Management},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {37},
  doi = {10.1002/advs.202519049}
}
Kostenlos starten →